Search Results - "Schub, Andrea"

Cross-sectional analysis of CD8 T cell immunity to human herpesvirus 6B by Martin, Larissa K, Hollaus, Alexandra, Stahuber, Anna, Hübener, Christoph, Fraccaroli, Alessia, Tischer, Johanna, Schub, Andrea, Moosmann, Andreas

“…Human herpesvirus 6 (HHV-6) is prevalent in healthy persons, causes disease in immunosuppressed carriers, and may be involved in autoimmune disease. Cytotoxic…”
Get full text

CMV-Specific TCR-Transgenic T Cells for Immunotherapy by Schub, Andrea, Schuster, Ingrid G, Hammerschmidt, Wolfgang, Moosmann, Andreas

“…Reactivation of CMV can cause severe disease after allogeneic hemopoietic stem cell transplantation. Adoptive T cell therapy was successfully used for patients…”
Get full text

Specific CD8+ T cells recognize human herpesvirus 6B by Martin, Larissa K., Schub, Andrea, Dillinger, Stefan, Moosmann, Andreas

“…The importance of human herpesvirus 6 (HHV‐6) species as human pathogens is increasingly appreciated. However, we do not understand how infection is controlled…”
Get full text

Specific CD 8 + T cells recognize human herpesvirus 6 B by Martin, Larissa K., Schub, Andrea, Dillinger, Stefan, Moosmann, Andreas

“…The importance of human herpesvirus 6 ( HHV ‐6) species as human pathogens is increasingly appreciated. However, we do not understand how infection is…”
Get full text

Specific CD 8 super(+) T cells recognize human herpesvirus 6 B by Martin, Larissa K, Schub, Andrea, Dillinger, Stefan, Moosmann, Andreas

“…The importance of human herpesvirus 6 ( HHV -6) species as human pathogens is increasingly appreciated. However, we do not understand how infection is…”
Get full text

Blinatumomab exposure and pharmacodynamic response in patients with non-Hodgkin lymphoma (NHL) by Hijazi, Youssef, Klinger, Matthias, Schub, Andrea, Wu, Benjamin, Zhu, Min, Kufer, Peter, Wolf, Andreas, Nagorsen, Dirk

“…Abstract only 3051 Background: Blinatumomab (AMG 103) is an investigational, bispecific, T cell engaging (BiTE) antibody targeting CD19-expressing B cells. We…”
Get full text

Immunopharmacodynamic response to blinatumomab in patients with relapsed/refractory B-precursor acute lymphoblastic leukemia (ALL) by Schub, Andrea, Nägele, Virginie, Zugmaier, Gerhard, Brandl, Christian, Hijazi, Youssef, Topp, Max S., Kufer, Peter, Wolf, Andreas, Klinger, Matthias

“…Abstract only 7020 Background: Blinatumomab is an anti-CD19/anti-CD3 bispecific T cell engager (BiTE) that induces target cell-dependent, polyclonal T cell…”
Get full text

A single TCR alpha-chain with dominant peptide recognition in the allorestricted HER2/neu-specific T cell repertoire by Liang, Xiaoling, Weigand, Luise U, Schuster, Ingrid G, Eppinger, Elfriede, van der Griendt, Judith C, Schub, Andrea, Leisegang, Matthias, Sommermeyer, Daniel, Anderl, Florian, Han, Yanyan, Ellwart, Joachim, Moosmann, Andreas, Busch, Dirk H, Uckert, Wolfgang, Peschel, Christian, Krackhardt, Angela M

“…T cells can recognize tumor cells specifically by their TCR and the transfer of TCR-engineered T cells is a promising novel tool in anticancer therapies. We…”
Get full text

A Single TCR{alpha}-Chain with Dominant Peptide Recognition in the Allorestricted HER2/neu-Specific T Cell Repertoire by Liang, Xiaoling, Weigand, Luise U, Schuster, Ingrid G, Eppinger, Elfriede, van der Griendt, Judith C, Schub, Andrea, Leisegang, Matthias, Sommermeyer, Daniel, Anderl, Florian, Han, Yanyan, Ellwart, Joachim, Moosmann, Andreas, Busch, Dirk H, Uckert, Wolfgang, Peschel, Christian, Krackhardt, Angela M

Get full text